GI
JAZZ icon

GAMMA Investing’s Jazz Pharmaceuticals JAZZ Stock Holding History

GAMMA Investing’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Buy
1,407
+223
+19% +$48.9K 0.01% 878
2026
Q1 		$224K Buy
1,184
+172
+17% +$30.1K 0.01% 1033
2025
Q4 		$172K Buy
1,012
+357
+55% +$54.7K 0.01% 1150
2025
Q3 		$86.3K Buy
655
+154
+31% +$18.5K ﹤0.01% 1607
2025
Q2 		$53.2K Sell
501
-514
-51% -$55.8K ﹤0.01% 1901
2025
Q1 		$126K Buy
1,015
+395
+64% +$51.5K 0.01% 1071
2024
Q4 		$76.4K Buy
620
+206
+50% +$24.3K 0.01% 1316
2024
Q3 		$46.1K Buy
414
+121
+41% +$13.3K ﹤0.01% 1544
2024
Q2 		$31.3K Buy
293
+116
+66% +$12.8K ﹤0.01% 1540
2024
Q1 		$21.3K Buy
177
+74
+72% +$9.06K ﹤0.01% 1611
2023
Q4 		$12.6K Buy
+103
New +$12.9K ﹤0.01% 1776

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

GAMMA Investing's JAZZ Position: Q2 2026 in Review

GAMMA Investing increased its Jazz Pharmaceuticals (JAZZ) stake by 19% in Q2 2026, buying an estimated $48.9K and bringing the position to 1,407 shares worth $339K. The position accounts for 0.01% of the portfolio, ranked #878.

GAMMA Investing first reported a position in JAZZ in Q4 2023 and has held it in 11 quarters since. 87 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • GAMMA Investing held 1,407 shares of Jazz Pharmaceuticals worth $339K as of Q2 2026.
  • GAMMA Investing bought 223 Jazz Pharmaceuticals shares in Q2 2026, an estimated $48.9K.
  • Jazz Pharmaceuticals made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #878 holding.
  • GAMMA Investing first reported a position in Jazz Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 87 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.